ENTRY       D03822                      Drug
NAME        Rivastigmine (JAN/USP/INN);
            Exelon (TN);
            Prometax (TN)
PRODUCT     EXELON (Novartis Pharmaceuticals Corporation)
  GENERIC   RIVASTIGMINE (Amneal Pharmaceuticals LLC)
            RIVASTIGMINE (Mylan Pharmaceuticals)
            RIVASTIGMINE (Northstar Rx LLC.)
            RIVASTIGMINE (Sandoz)
            RIVASTIGMINE (Zydus Lifesciences Limited)
            RIVASTIGMINE (Zydus Pharmaceuticals USA)
            RIVASTIGMINE TRANSDERMAL SYSTEM (Adhexpharma)
            RIVASTIGMINE TRANSDERMAL SYSTEM (Alvogen)
            RIVASTIGMINE TRANSDERMAL SYSTEM (Breckenridge Pharmaceutical)
            RIVASTIGMINE TRANSDERMAL SYSTEM (Bryant Ranch Prepack)
            RIVASTIGMINE TRANSDERMAL SYSTEM (Bryant Ranch Prepack)
            RIVASTIGMINE TRANSDERMAL SYSTEM (Bryant Ranch Prepack)
            RIVASTIGMINE TRANSDERMAL SYSTEM (Bryant Ranch Prepack)
            RIVASTIGMINE TRANSDERMAL SYSTEM (Bryant Ranch Prepack)
            RIVASTIGMINE TRANSDERMAL SYSTEM (Bryant Ranch Prepack)
FORMULA     C14H22N2O2
EXACT_MASS  250.1681
MOL_WEIGHT  250.3367
CLASS       Neuropsychiatric agent
             DG01595  Cholinesterase inhibitor
              DG01593  Acetylcholinesterase inhibitor
              DG01594  Butyrylcholinesterase inhibitor
             DG01968  Antidementia agent
REMARK      Same as: C11766
            Therapeutic category: 1190
            ATC code: N06DA03
            Chemical structure group: DG00984
            Product (DG00984): D03822<JP/US> D02558<US>
EFFICACY    Dementia therapeutic agent, Acetylcholinesterase inhibitor
  DISEASE   Alzheimer's disease [DS:H00056]
COMMENT     Physostigmine derivative
TARGET      ACHE [HSA:43] [KO:K01049]
            BCHE [HSA:590] [KO:K01050]
  PATHWAY   hsa00564(43)  Glycerophospholipid metabolism
            hsa04725(43)  Cholinergic synapse
INTERACTION  
STR_MAP     map07056  Agents for Alzheimer-type dementia
            map07220  Cholinergic and anticholinergic drugs
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N06 PSYCHOANALEPTICS
               N06D ANTI-DEMENTIA DRUGS
                N06DA Anticholinesterases
                 N06DA03 Rivastigmine
                  D03822  Rivastigmine (JAN/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antidementia Agents
              Cholinesterase Inhibitors
               Rivastigmine
                D03822  Rivastigmine (JAN/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               119  Miscellaneous
                1190  Miscellaneous
                 D03822  Rivastigmine (JAN/USP/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01595  Cholinesterase inhibitor
               DG01593  Acetylcholinesterase inhibitor
                DG00984  Rivastigmine
                 D03822  Rivastigmine
               DG01594  Butyrylcholinesterase inhibitor
                DG00984  Rivastigmine
                 D03822  Rivastigmine
              DG01968  Antidementia agent
               DG00984  Rivastigmine
                D03822  Rivastigmine
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG01968  Antidementia agent
               D03822  Rivastigmine
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Carboxylic-ester hydrolases
                ACHE
                 D03822  Rivastigmine (JAN/USP/INN) &lt;JP/US&gt;
                BCHE
                 D03822  Rivastigmine (JAN/USP/INN) &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D03822
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D03822
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01595  Cholinesterase inhibitor
               DG01593  Acetylcholinesterase inhibitor
                DG00984  Rivastigmine
               DG01594  Butyrylcholinesterase inhibitor
                DG00984  Rivastigmine
              DG01968  Antidementia agent
               DG00984  Rivastigmine
DBLINKS     CAS: 123441-03-2
            PubChem: 17397908
            ChEBI: 8874
            LigandBox: D03822
            NIKKAJI: J982.502I
ATOM        18
            1   C8y C    33.4600  -18.9700
            2   C8x C    34.6500  -18.2700
            3   C8x C    33.4600  -20.3700
            4   O7a O    32.2000  -18.2700
            5   C8y C    35.8400  -18.9700
            6   C8x C    34.6500  -21.0700
            7   C7a C    31.0100  -18.9700
            8   C8x C    35.8400  -20.3700
            9   N1c N    29.8200  -18.2700
            10  O6a O    31.0100  -20.3700
            11  C1a C    28.5600  -18.9700
            12  C1c C    37.1000  -18.2700
            13  N1c N    38.2900  -18.9700
            14  C1a C    37.1000  -16.8700
            15  C1a C    38.2900  -20.3700
            16  C1a C    39.4800  -18.2700
            17  C1b C    29.8200  -16.8700
            18  C1a C    31.0800  -16.1700
BOND        18
            1     5   8 2
            2     7   9 1
            3     7  10 2
            4     9  11 1
            5     6   8 1
            6     5  12 1
            7     1   2 2
            8    12  13 1
            9     1   3 1
            10   12  14 1 #Down
            11    1   4 1
            12   13  15 1
            13    2   5 1
            14   13  16 1
            15    3   6 2
            16    9  17 1
            17    4   7 1
            18   17  18 1
///
